HOME >> BIOLOGY >> NEWS
Cell's gatekeeper for ammonia revealed in unprecedented detail

Bacteria thrive on it, red blood cells carry it in high concentration, yet the human brain can't tolerate it. The ability of cells to acquire or dispose of ammonia can be a matter of life and death. In the September 10 issue of Science, UCSF researchers publish the first atomic-level structure of the channel that controls the passage of ammonia in and out of cells.

The complex structure -- depicted on the cover of Science -- was determined in greater detail than that of any cell membrane channel yet described. The structure can help reveal the molecular basis of often life-threatening diseases caused by ammonia toxicity, and provides the "template for designing drugs to treat the diseases," said Robert Stroud, PhD, professor of biochemistry and biophysics and of pharmaceutical chemistry at UCSF and senior author of the paper in Science.

Knowledge of the channel architecture is also expected to help explain how ammonia, carbon dioxide and other gases are taken in, transported between cells and excreted, the scientists said.

The issue of Science also includes a "Perspective" article about the significance of determining the structure and its likely mode of action.

The three-dimensional shape of other cell membrane channels -- those that conduct water and charged molecules called ions -- have been reported over the past six years. In 2000, Stroud's group was the first to discover the structure and mechanisms of the water-conducting channels.

To determine the structure of an ammonia channel, the UCSF scientists focused on AmtB, a protein that facilitates ammonia uptake in bacteria. The bacterial AmtB is a member of a "superfamily" of protein channels with very similar amino acid sequences and very similar functions in all species. Humans have four members of this superfamily of cell membrane channels. They are the Rh factors, most familiar as the Rh blood group antigens on the surface of red blood cells that can caus
'"/>

Contact: Wallace Ravven
wravven@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
9-Sep-2004


Page: 1 2 3

Related biology news :

1. Scientists Determine Atomic Structure Of Lego-Like Molecule That Self-Assembles Into Cells Cargo Capsule
2. UCSF team reveals how the most selective of all cell gatekeepers works -- a three-faced channel vital to most human organs
3. Asian elephant sex pheromone transporter revealed
4. Brains reward circuitry revealed in procrastinating primates
5. Endangered turtles trek along ocean currents revealed by satellite
6. Secret behind hard exoskeletons, spreading wings revealed
7. Genetic basis of hereditary nerve disorder revealed
8. Biochemical clues to long lifespan revealed
9. Enzyme revealed that is key to funguss ability to breach immune system
10. Bacterial relationships revealed
11. Genetic differences revealed by SNPS play a role in risk, prevention and outcome for cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cell gatekeeper for ammonia revealed unprecedented detail

(Date:5/22/2013)... endanger the whole organism, as they may lead to ... Munich now report how byproducts of respiration cause mispairing ... in our cells controls the form and function of ... this are encoded in the linear sequence of the ... cytosine (C), guanine (G) and thymine (T). Random changes ...
(Date:5/22/2013)... and wild plants have slowed in recent years, according ... University of Leeds and the Naturalis Biodiversity Centre in ... the diversity of species in Britain, Belgium and the ... picture brightened markedly after 1990, with a slowdown in ... wild plants. , Professor Bill Kunin, Professor ...
(Date:5/21/2013)... "place" is increasingly being considered in the management ... new resource that can help them recognize and ... places in their lives. , Place-Based Conservation: ... co-edited by the Pacific Northwest Research Station,s Linda ... to conservation. The book is published by Springer ...
Breaking Biology News(10 mins):DNA damage: The dark side of respiration 2Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3
(Date:5/22/2013)... New York (PRWEB) May 22, 2013 ... the 3rd Annual Disruptive Innovations to Advance Clinical Trials ... Copley Plaza Hotel in Boston, MA. , Disruptive ... Janssen Pharmaceuticals and more share bold approaches to reduce ... , “Disruptive innovation needs to be big, or ...
(Date:5/22/2013)... Genedata, a leading provider of ... and life science research, today announced AB Enzymes ... its bioinformatics platform for strain genome data management ... AB Enzymes, one of the world’s oldest and ... Genedata Selector accompanied by bioinformatics consulting services. Genedata ...
(Date:5/22/2013)... IL (PRWEB) May 22, 2013 Alton Housing ... dated May 15, 2013 said that their presence has ... other bed bug sufferers avoid such big spending, My Cleaning ... inexpensively. , It was said in the report that ... exterminator, MCP related. Apart from that, its employees also attended ...
(Date:5/21/2013)... , May 22, 2013 ... drug-only formulation of glycopyrronium bromide designed using Prosonix, particle ... company developing a portfolio of inhaled Respiratory Medicines ... study with PSX1002 that will assess its effect on ... doses in patients with moderate to severe chronic obstructive ...
Breaking Biology Technology:Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4Bed Bugs Cost Alton Housing Authority $35,000; New Help, How to Kill Bed Bugs With Less Expense, Introduced by My Cleaning Products 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4
Cached News: